Literature DB >> 14738918

Validation of a chiral HPLC assay for (R)-salbutamol sulfate.

Alejandra Halabi1, Carlos Ferrayoli, Marcela Palacio, Viviana Dabbene, Sara Palacios.   

Abstract

A fast, reliable and specific method for the screening, confirmation, determination and quantitation of salbutamol enantiomers was developed and validated. The described procedure includes a single robust chiral HPLC determination employing a Teicoplanin stationary phase. The method was evaluated for specificity, robustness, linearity, precision and accuracy. Under the chromatographic conditions of the method, known impurities were separated from the active principle.

Mesh:

Substances:

Year:  2004        PMID: 14738918     DOI: 10.1016/j.japna.2003.08.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Fabrication and In Vitro/In Vivo Appraisal of Metronidazole Intra-Gastric Buoyant Sustained-Release Tablets in Healthy Volunteers.

Authors:  Mohammed H Elkomy; Heba A Abou-Taleb; Hussein M Eid; Heba A Yassin
Journal:  Pharmaceutics       Date:  2022-04-14       Impact factor: 6.525

2.  Techniques to develop and characterize nanosized formulation for salbutamol sulfate.

Authors:  F J Ahmad; R K Khar; S Sultana; A Bhatnagar
Journal:  J Mater Sci Mater Med       Date:  2008-06-10       Impact factor: 3.896

3.  Spectrofluorimetric estimation of salbutamol sulphate in different dosage forms by formation of inclusion complex with β-cyclodextrin.

Authors:  Harshit Narmadashankar Pandya; Hiren Harshadlal Berawala; Deepak Mohanlal Khatri; Priti Jignesh Mehta
Journal:  Pharm Methods       Date:  2010-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.